These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 7940925

  • 1. Use of Sandimmun Neoral in renal transplant patients. International Sandimmun Neoral Study Group.
    Frei U, Taesch S, Niese D.
    Transplant Proc; 1994 Oct; 26(5):2928-31. PubMed ID: 7940925
    [No Abstract] [Full Text] [Related]

  • 2. A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months. The International Sandimmun Neoral Study Group.
    Niese D.
    Transplant Proc; 1995 Apr; 27(2):1849-56. PubMed ID: 7725531
    [No Abstract] [Full Text] [Related]

  • 3. A randomized, controlled, double-blind study of the safety and tolerability of Sandimmun Neoral in stable renal transplant patients. Argentine Multicentre Study Group.
    Massari PU, Grosso S, de Boccardo G, Vásquez MC, Schiavelli RO, Sabbatiello RR, Casadei DH, Rial MC, Jost LJ, Túrin MD, Agost Carreño C A, Maggiora EC, Gadea MM.
    Transplant Proc; 1996 Dec; 28(6):3365-7. PubMed ID: 8962310
    [No Abstract] [Full Text] [Related]

  • 4. Safety and tolerability of CyA microemulsion formulation (Sandimmun Neoral) in stable renal transplant patients after 24 months of treatment. German Neoral Study Group.
    Offermann G, Korn A.
    Transplant Proc; 1996 Aug; 28(4):2204-6. PubMed ID: 8769201
    [No Abstract] [Full Text] [Related]

  • 5. Experience with clinical use of Sandimmun Neoral in renal transplant patients.
    Min ZL, Zhao M, Zhu YH, Qi J, Wang LM, Wang YW.
    Transplant Proc; 1996 Jun; 28(3):1356-7. PubMed ID: 8658692
    [No Abstract] [Full Text] [Related]

  • 6. Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.
    Buchholz B, Korn A.
    Transplant Proc; 1996 Aug; 28(4):2187-8. PubMed ID: 8769195
    [No Abstract] [Full Text] [Related]

  • 7. Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study Group.
    Barone G, Bunke CM, Choc MG, Hricik DE, Jin JH, Klein JB, Marsh CL, Min DI, Pescovitz MD, Pollak R, Pruett TL, Stinson JB, Thompson JS, Vasquez E, Waid T, Wombolt DG, Wong RL.
    Transplant Proc; 1996 Aug; 28(4):2183-6. PubMed ID: 8769194
    [No Abstract] [Full Text] [Related]

  • 8. Conversion from Sandimmun to Sandimmun Neoral in patients with stable renal allografts: results after 1 month.
    Neumayer HH, Färber L, Haller P, Kohnen R, Maibücher A, Schuster A, Vollmar J, Waiser J.
    Transplant Proc; 1994 Oct; 26(5):2944-8. PubMed ID: 7940929
    [No Abstract] [Full Text] [Related]

  • 9. A randomized, controlled trial to assess the safety of switching stable renal transplant patients from Sandimmun to Sandimmun Neoral.
    Loo CS, Morad Z, Lim TO, Fan KS, Suleiman AB.
    Transplant Proc; 1996 Jun; 28(3):1328-9. PubMed ID: 8658680
    [No Abstract] [Full Text] [Related]

  • 10. Sandimmun neoral, a new oral formulation of cyclosporin A with improved pharmacokinetic characteristics: safety and tolerability in renal transplant patients.
    Taesch S, Niese D, Mueller EA.
    Transplant Proc; 1994 Dec; 26(6):3147-9. PubMed ID: 7998097
    [No Abstract] [Full Text] [Related]

  • 11. Clinical study of sandimmun neoral in cadaveric renal transplantation.
    Xue W, Chen Y, Xing J, Tian P.
    Transplant Proc; 1996 Jun; 28(3):1333-4. PubMed ID: 8658682
    [No Abstract] [Full Text] [Related]

  • 12. Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.
    Løkkegaard H, Asmundsson P, Clausen P, Dieperink H, Hansen JM, Heaf J, Jensen SB, Kornerup HJ, Madsen S, Pedersen EB, Poulsen JV, Rasmussen K.
    Transplant Proc; 1996 Aug; 28(4):2199-201. PubMed ID: 8769199
    [No Abstract] [Full Text] [Related]

  • 13. Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients.
    Tsang WK, Ho YW, Tong KL, Chan WH, Chan A.
    Transplant Proc; 1996 Jun; 28(3):1330-2. PubMed ID: 8658681
    [No Abstract] [Full Text] [Related]

  • 14. Clinical experience in transferring kidney transplant patients from sandimmun to sandimmun neoral--results after 6 months.
    Neumayer HH, Färber L, Haller P, Kohnen R, Maibücher A, Schuster A, Vollmar J, Waiser J.
    Transplant Proc; 1995 Oct; 27(5):2679-82. PubMed ID: 7482873
    [No Abstract] [Full Text] [Related]

  • 15. Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patients.
    Taesch S, Niese D.
    Transpl Int; 1994 Oct; 7 Suppl 1():S263-6. PubMed ID: 11271220
    [Abstract] [Full Text] [Related]

  • 16. Conversion from Sandimmune to Neoral in stable renal transplant recipients. Sandoz Study Group OLN-353.
    Pescovitz MD.
    Transplant Proc; 1996 Aug; 28(4):2196-8. PubMed ID: 8769198
    [No Abstract] [Full Text] [Related]

  • 17. A study to assess the efficacy, tolerability, and safety of a new oral formulation of Sandimmun--Sandimmun Neoral--in stable renal transplant patients.
    Rosental R, Bicans J, Berzina R, Zezina L.
    Transplant Proc; 1995 Dec; 27(6):3436-7. PubMed ID: 8540038
    [No Abstract] [Full Text] [Related]

  • 18. Long-term experience with Sandimmun Neoral: results in de novo and stable renal transplant patients after 24-month treatment. The German Neoral Study Group.
    Korn A, Färber L, Maibücher A, Buchholz B, Offermann G.
    Transplant Proc; 1997 Nov; 29(7):2945-7. PubMed ID: 9365623
    [No Abstract] [Full Text] [Related]

  • 19. Cyclosporine pharmacokinetic profiles in stable renal allograft recipients converting from Sandimmun to Neoral.
    Vathsala A, Lee WT, Jacob E, Woo KT.
    Transplant Proc; 1996 Jun; 28(3):1324-6. PubMed ID: 8658678
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of efficacy, safety, and tolerability of Neoral vs Sandimmun in de novo renal transplant patients over 24 months' treatment.
    Abendroth D, Buchholz B, Land W, May G, Wiesel M, Färber L, Korn A, Maibücher A.
    Transplant Proc; 1997 Jun; 29(1-2):275-6. PubMed ID: 9122993
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.